Related references
Note: Only part of the references are listed.NRF2 Activation in Cancer: From DNA to Protein
Erica W. Cloer et al.
CANCER RESEARCH (2019)
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Michael E. Bregenzer et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance
Maria R. Ward Rashidi et al.
NEOPLASIA (2019)
Plumbagin-induced oxidative stress leads to inhibition of Na+/K+-ATPase (NKA) in canine cancer cells
Yousef Alharbi et al.
SCIENTIFIC REPORTS (2019)
Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death
Francois Fabi et al.
CELL COMMUNICATION AND SIGNALING (2018)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites
Martyna Pakula et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin
Arvinder Kapur et al.
SCIENTIFIC REPORTS (2018)
Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
Amruta P. Nayak et al.
CANCERS (2018)
Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii
Christine Robin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Na/K Pump and Beyond: Na/K-ATPase as a Modulator of Apoptosis and Autophagy
Cassiano Felippe Goncalves-de-Albuquerque et al.
MOLECULES (2017)
Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells
Aditi Banerjee et al.
ONCOTARGET (2017)
Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
Shreya Raghavan et al.
CLINICAL CANCER RESEARCH (2017)
Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer
Eileen E. Parkes et al.
ONCOLOGIST (2016)
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
Thomas M. Ashton et al.
NATURE COMMUNICATIONS (2016)
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
Junli Deng et al.
ONCOTARGET (2016)
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Luigi Ippolito et al.
ONCOTARGET (2016)
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
Marco Fiorillo et al.
ONCOTARGET (2016)
Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer
Young Eun Choi et al.
CELL REPORTS (2016)
TP53 mutations in epithelial ovarian cancer
Yu Zhang et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation
Arvinder Kapur et al.
SCIENTIFIC REPORTS (2016)
Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays
Shreya Raghavan et al.
GYNECOLOGIC ONCOLOGY (2015)
Metabolic responses induced by DNA damage and poly (ADP-ribose) polymerase (PARP) inhibition in MCF-7 cells
Vijesh J. Bhute et al.
METABOLOMICS (2015)
Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents
N. Yadav et al.
CELL DEATH & DISEASE (2015)
Metabolic requirements for the maintenance of self-renewing stem cells
Keisuke Ito et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action
Dominic Birth et al.
NATURE COMMUNICATIONS (2014)
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
Anna Pasto et al.
ONCOTARGET (2014)
Oxidative phosphorylation in cancer cells
Giancarlo Solaini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
Mitochondrial Electron Transport Inhibition and Viability of Intraerythrocytic Plasmodium falciparum
Heather J. Painter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies
Saroj P. Mathupala et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
How mitochondria produce reactive oxygen species
Michael P. Murphy
BIOCHEMICAL JOURNAL (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Exploring the inhibitor binding pocket of respiratory complex I
Uta Fendel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2008)
Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum
Heather J. Painter et al.
NATURE (2007)
Mitochondrial free radical generation, oxidative stress, and aging
E Cadenas et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
